Sunday, September 13, 2026

CBOE Drops By 16% In The Last 21 Sessions

CBOE Drops By 16% In The Last 21 Sessions

(VIANEWS) - CBOE (VIX) has been up by 16.77% for the last 21 sessions. At 04:09 EST on Thursday, 9 May, CBOE (VIX) is $13.15.

Concerning CBOE's yearly highs and lows, it's 0.61% up from its 52-week low and 62.48% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a negative 4.19%, a negative 0.69%, and a positive 4.29%, respectively.

CBOE's highest amplitude of average volatility was 4.19% (last week), 5.19% (last month), and 4.29% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 7 May, "The S&P 500 equal weighted index is also lagging the S&P 500 market-cap weighted index, which also suggests that the risk-on tone to markets triggered by a less hawkish Fed and weaker than expected US payrolls is benefiting the largest US companies."
  • According to FXStreet on Tuesday, 7 May, "The S&P 500 opens on a cautiously positive note, suggesting an improvement in investors' risk appetite. "
  • According to FXStreet on Tuesday, 7 May, "The Dow Jones Industrial Average, S&P 500 and NASDAQ Composite have all advanced between 0.1% and 0.3% at the time of writing."
  • According to Zacks on Tuesday, 7 May, "In that same time, the Retail-Wholesale sector gained 0.98%, while the S&P 500 lost 0.35%."

More news about CBOE (VIX).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com